Top compounds associated with response to CREBL2


Feature Type Standardized
Nominal ANOVA
mRNA embelin GDSC1000 pan-cancer AAC -0.11 0.003
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA BX-912 GDSC1000 pan-cancer AAC -0.094 0.003
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.1 0.003
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.003
mRNA etoposide GDSC1000 pan-cancer AAC -0.11 0.003
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC -0.17 0.003
mRNA GW843682X GDSC1000 pan-cancer AAC -0.17 0.003
mRNA lapatinib CCLE pan-cancer AAC -0.13 0.004
mRNA Bortezomib gCSI pan-cancer AAC -0.19 0.004
Download CSV